Glioma gene therapy with soluble transforming growth factor-beta receptors ii and iii.
October 6th, 2008 by 
admin | Related Articles |
Glioma factor therapy with solvable transforming ontogeny factor-beta receptors II and III.
Int J Oncol. 2008 Oct;33(4):759-65
Authors: Naumann U, Maass P, Gleske AK, Aulwurm S, Weller M, Eisele G
Transforming ontogeny factor-beta (TGF-beta) is extravagantly spoken in cancerous gliomas and is pivotal for the ontogeny micromilieu. TGF-beta not exclusive enhances migration and entrance of glioma cells but also inhibits an trenchant anti-glioma insusceptible response. TGF-beta mediates its life personalty finished interactions with TGF-beta receptors (TbetaR)-I to -III. Binding of TGF-beta leads to the activation of an intracellular communication fall and ensuant phosphorylation of Sma and MAD-related proteins (SMAD). Soluble TGF-beta receptors (TbetaRs) abrogate the TGF-beta gist by competing for the protection of the ligand to its receptor. Here we utilised adenoviral factor designate to impart TbetaR-IIs and -IIIs in manlike glioma radiophone lines. TbetaR-IIs low SMAD2 phosphorylation and TGF-beta-dependent communicator activity. Furthermore, it enhanced glioma radiophone lysis by uncolored dolphin cells. TbetaR-IIIs lonely were indolent in these assays, but enhanced the personalty of TbetaR-IIs. Transduction of LN-308 cells with TbetaRs markedly suspended ontogeny of intracerebral xenografts in someone mice in vivo. These accumulation advert TbetaRs for doable empiric therapy of gliomas.
PMID: 18813789 [PubMed - in process]
(Source: International Journal of Oncology)
MedWorm Sponsored Message: Find discover how you crapper get your communication crossways here by sponsoring this MedWorm programme feed.
Posted in Cancer | 